These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26304866)

  • 1. Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation.
    Kate M; Gioia L; Buck B; Sivakumar L; Jeerakathil T; Shuaib A; Butcher K
    Stroke; 2015 Sep; 46(9):2685-7. PubMed ID: 26304866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dabigatran Treatment of Acute Noncardioembolic Ischemic Stroke.
    Butcher KS; Ng K; Sheridan P; Field TS; Coutts SB; Siddiqui M; Gioia LC; Buck B; Hill MD; Miller J; Klahr AC; Sivakumar L; Benavente OR; Hart RG; Sharma M
    Stroke; 2020 Apr; 51(4):1190-1198. PubMed ID: 32098609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of early initiation of rivaroxaban or dabigatran after thrombolysis in acute ischemic stroke.
    Ritzenthaler T; Derex L; Davenas C; Bnouhanna W; Farghali A; Mechtouff L; Cho TH; Nighoghossian N
    Rev Neurol (Paris); 2015 Sep; 171(8-9):613-5. PubMed ID: 25857461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proposed approach to thrombolysis in dabigatran-treated patients presenting with ischemic stroke.
    Kate M; Szkotak A; Witt A; Shuaib A; Butcher K
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1351-5. PubMed ID: 24406026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early Dabigatran Treatment After Transient Ischemic Attack and Minor Ischemic Stroke Does Not Result in Hemorrhagic Transformation.
    Alrohimi A; Ng K; Dowlatshahi D; Buck B; Stotts G; Thirunavukkarasu S; Shamy M; Kalashyan H; Sivakumar L; Shuaib A; Sharma M; Butcher K
    Can J Neurol Sci; 2020 Sep; 47(5):604-611. PubMed ID: 32342831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke.
    Tziomalos K; Giampatzis V; Bouziana SD; Spanou M; Kostaki S; Papadopoulou M; Angelopoulou SM; Konstantara F; Savopoulos C; Hatzitolios AI
    Blood Coagul Fibrinolysis; 2016 Mar; 27(2):185-9. PubMed ID: 26366831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available Evidence.
    Pikija S; Sztriha LK; Sebastian Mutzenbach J; Golaszewski SM; Sellner J
    CNS Drugs; 2017 Sep; 31(9):747-757. PubMed ID: 28808918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dabigatran following acute transient ischemic attack and minor stroke II (DATAS II).
    Ng KH; Sharma M; Benavente O; Gioia L; Field TS; Hill MD; Coutts SB; Butcher K;
    Int J Stroke; 2017 Oct; 12(8):910-914. PubMed ID: 28585903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of dabigatran therapy in daily-care patients with atrial fibrillation. Results from the Dresden NOAC Registry.
    Beyer-Westendorf J; Ebertz F; Förster K; Gelbricht V; Michalski F; Köhler C; Werth S; Endig H; Pannach S; Tittl L; Sahin K; Daschkow K; Weiss N
    Thromb Haemost; 2015 Jun; 113(6):1247-57. PubMed ID: 25739533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
    Ohya Y; Makihara N; Wakisaka K; Morita T; Ago T; Kitazono T; Takaba H
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e128-e131. PubMed ID: 29555397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests.
    Cho HJ; Kang YJ; Sung SM; Ahn SH; Jung YH; Lee KY; Seo JH; Han SW; Park JH; Choi HY; Kwon JH; Kim WJ; Park HJ; Choi JK; Nam HS; Heo JH; Kim YD
    PLoS One; 2020; 15(10):e0240483. PubMed ID: 33044991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Thrombolysis in Acute Ischemic Stroke after Dabigatran Etexilate Reversal with Idarucizumab-A Case Report.
    Tireli D; He J; Nordling MM; Wienecke T
    J Stroke Cerebrovasc Dis; 2017 Jul; 26(7):e123-e125. PubMed ID: 28479184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early Rivaroxaban Use After Cardioembolic Stroke May Not Result in Hemorrhagic Transformation: A Prospective Magnetic Resonance Imaging Study.
    Gioia LC; Kate M; Sivakumar L; Hussain D; Kalashyan H; Buck B; Bussiere M; Jeerakathil T; Shuaib A; Emery D; Butcher K
    Stroke; 2016 Jul; 47(7):1917-9. PubMed ID: 27222524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Hansen TM; von Weitzel-Mudersbach P; Simonsen CZ; Damgaard D; Gottrup H; Svendsen K; Rasmussen PV; Ribe LR; Mikkelsen IK; Nagenthiraja K; Cho TH; Redington AN; Bøtker HE; Østergaard L; Mouridsen K; Andersen G
    Stroke; 2014 Jan; 45(1):159-67. PubMed ID: 24203849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dabigatran use in elderly patients with atrial fibrillation.
    Avgil-Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Behlouli H; Pilote L
    Thromb Haemost; 2016 Jan; 115(1):152-60. PubMed ID: 26354766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Idarucizumab-facilitated intravenous thrombolysis in acute stroke with dabigatran: Two cases with hemorrhagic transformation.
    Tsai YT; Hsiao YJ; Tsai LK; Yen PS; Lin FY; Lu CH; Fang CW
    J Neurol Sci; 2018 May; 388():155-157. PubMed ID: 29627012
    [No Abstract]   [Full Text] [Related]  

  • 17. The Long-Term Multicenter Observational Study of Dabigatran Treatment in Patients With Atrial Fibrillation (RELY-ABLE) Study.
    Connolly SJ; Wallentin L; Ezekowitz MD; Eikelboom J; Oldgren J; Reilly PA; Brueckmann M; Pogue J; Alings M; Amerena JV; Avezum A; Baumgartner I; Budaj AJ; Chen JH; Dans AL; Darius H; Di Pasquale G; Ferreira J; Flaker GC; Flather MD; Franzosi MG; Golitsyn SP; Halon DA; Heidbuchel H; Hohnloser SH; Huber K; Jansky P; Kamensky G; Keltai M; Kim SS; Lau CP; Le Heuzey JY; Lewis BS; Liu L; Nanas J; Omar R; Pais P; Pedersen KE; Piegas LS; Raev D; Smith PJ; Talajic M; Tan RS; Tanomsup S; Toivonen L; Vinereanu D; Xavier D; Zhu J; Wang SQ; Duffy CO; Themeles E; Yusuf S
    Circulation; 2013 Jul; 128(3):237-43. PubMed ID: 23770747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte colony-stimulating factor in patients with acute ischemic stroke: results of the AX200 for Ischemic Stroke trial.
    Ringelstein EB; Thijs V; Norrving B; Chamorro A; Aichner F; Grond M; Saver J; Laage R; Schneider A; Rathgeb F; Vogt G; Charissé G; Fiebach JB; Schwab S; Schäbitz WR; Kollmar R; Fisher M; Brozman M; Skoloudik D; Gruber F; Serena Leal J; Veltkamp R; Köhrmann M; Berrouschot J;
    Stroke; 2013 Oct; 44(10):2681-7. PubMed ID: 23963331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of dabigatran compared with warfarin in relation to baseline renal function in patients with atrial fibrillation: a RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) trial analysis.
    Hijazi Z; Hohnloser SH; Oldgren J; Andersson U; Connolly SJ; Eikelboom JW; Ezekowitz MD; Reilly PA; Siegbahn A; Yusuf S; Wallentin L
    Circulation; 2014 Mar; 129(9):961-70. PubMed ID: 24323795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
    Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
    J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.